UNSPSC 85813909: Introduction of serum, toxoid and vaccine into muscle, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of serum, toxoid and vaccine into muscle, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0234Z

UNSPSC 85813909 Introduction of serum, toxoid and vaccine into muscle, percutaneous approach is a Commodity code that carries minimal direct relevance to state and local government procurement activity. The code nominally describes a clinical procedure—intramuscular injection of immunological agents—yet the recent opportunities tagged under it span telehealth, emergency medical services, cancer screening, occupational health, behavioral health, and specialty medical services, none of which map cleanly to vaccine administration or relate to each other in coherent procurement streams.

The issuing bodies active under this code include health authorities (Inland Empire Health Plan in California; Nevada Health Authority), county health systems (Santa Clara, Solano, San Mateo), county sheriffs and jails (Boulder County, Jackson County, Seminole County), state departments (Texas HHSC, Colorado Department of Human Services, Illinois Secretary of State), cities (Phoenix, Atlanta, Ocala), and school districts (Parkway School District in Missouri). Geographic spread covers California, Colorado, Florida, Georgia, Illinois, Kansas, Missouri, Nevada, New York, Oregon, Texas, and Virginia—a fragmented national footprint with no concentration. Recent solicitations show no pattern of repeated buyers or service lines; each opportunity addresses a distinct service category. Representative recent postings include Inland Empire Health Plan's RFI for virtual urgent care services (October 31, 2026 response due), Nevada Health Authority's RFP for PACE operations (December 10, 2026), and San Mateo Medical Center's RFP for cancer registry services (November 6, 2026). The code appears misaligned with actual procurement activity and does not represent a coherent market opportunity—skip in favor of codes with tighter commodity alignment and clearer buyer intent.